Publication | Open Access
Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations
42
Citations
37
References
2019
Year
These data support the development of D2C7-IT and immune checkpoint blockade combinations for patients with malignant glioma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1